Why individualised homeopathy is difficult—but not impossible—to test
When different patients receive different prescriptions, a simple one-pill trial may miss the practice model. Better research tests the strategy while preserving fair comparison.
The direct answer
In brief
Individualisation complicates research because the prescription varies by patient, but it does not make controlled testing impossible. Trials can randomise access to the complete consultation-and-prescribing strategy or standardise the decision process.
Key takeaways
- Complex or personalised care can still be evaluated with pragmatic and strategy-level trial designs.
- Researchers must separate consultation effects from the specific effect attributed to a preparation.
- Flexibility increases the importance of preregistration, transparent rules and independent replication.
Why does individualisation complicate a standard trial?
Two participants with the same diagnosis may receive different preparations, making a single-product comparison a poor representation of the claimed practice.
How can researchers test the whole strategy?
Participants can be randomised to a defined individualised-care pathway or a credible comparison, while outcomes and analysis are set before results are known.
What must still be controlled?
Attention, expectation, co-interventions, treatment switching, missing data and selective outcome reporting can influence results even when the prescription is personalised.
Does complexity excuse weak evidence?
No. Complexity affects study design, not the need for transparency, sufficient sample size, meaningful outcomes and reproducible findings.
Questions people also ask
Can personalised medicine be studied scientifically?
Yes. Many complex and personalised interventions are studied using pragmatic, adaptive or strategy-level designs.
Why not rely only on case reports?
Case reports can generate questions but cannot reliably separate the intervention from natural change, expectation, selection and other care.
Sources and signals
Official and research sources support factual claims. Reporting and community links document the conversation or demand signal; popularity is not clinical proof.
Follow on Google
Get our articles surfaced with a “preferred” badge in Google Search, Top Stories, and AI Mode.
Can’t see the button? Add us directly.